1-4 of 4
Luk Cox
Close
Sort by
Journal Articles

JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model

Degryse Sandrine, Charles E de Bock, PhD, Carmen Vicente, PhD, Luk Cox, PhD, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Thomas Tousseyn, PhD, Jan Cools, PhD
Journal: Blood
Blood (2014) 124 (21): 361.
https://doi.org/10.1182/blood.V124.21.361.361
Published: 2014
Journal Articles

JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model

Sandrine Degryse, Charles E. de Bock, Luk Cox, Sofie Demeyer, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Valentina Gianfelici, Gert Hulselmans, Mark Fiers, Stein Aerts, Jules P. Meijerink, Thomas Tousseyn, Jan Cools
Journal: Blood
Blood (2014) 124 (20): 3092–3100.
https://doi.org/10.1182/blood-2014-04-566687
Published: 2014
Includes: Supplemental data
Journal Articles

JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma

Clinical Trials & Observations
Katrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, Idoya Lahortiga, Olga Gielen, Barbara Cauwelier, Pascale De Paepe, Gregor Verhoef, Peter Marynen, Peter Vandenberghe, Chris De Wolf-Peeters, Jan Cools, Iwona Wlodarska
Journal: Blood
Blood (2011) 117 (15): 4056–4064.
https://doi.org/10.1182/blood-2010-06-291310
Published: 2011
Includes: Supplemental data
Journal Articles

JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma.

Katrien Van Roosbroeck, Luk Cox, PhD, Idoya Lahortiga, PhD, Olga Gielen, Thomas Tousseyn, MD, PhD, Barbara Cauwelier, PhD, Pascale De Paepe, MD, PhD, Peter Vandenberghe, MD, PhD, Peter Marynen, PhD, Chris De Wolf-Peeters, MD, PhD, Jan Cools, PhD, Iwona Wlodarska, PhD
Journal: Blood
Blood (2009) 114 (22): 140.
https://doi.org/10.1182/blood.V114.22.140.140
Published: 2009